Charting New Roads
Awareness changes your destiny
How Alzheimer’s Villages Are Helping Mitigate the Effects of Dementia
In a fascinating medical/social initiative, the Village Landais Alzheimer (Landes Alzheimer’s Village) in France took in 105 individuals with early to late-stage Alzheimer’s to study
Why The Northern Charitable Foundation Sponsors the Prevention GENEration Program
We are very passionate about sponsoring the Israel Cancer Association’s Prevention GENEration Program in collaboration with The Israel Hereditary Breast and Ovarian Cancer Consortium. The
Looking Towards the Future: WHO Reports Alarming Increase in Dementia and Worrisome Projections
As the Baby Boom generation ages, the World Health Organization (WHO) has reported a significant increase in cases of dementia. There were some 55 million
New Studies Show Cleaner Air Could Lower Susceptibility to Dementia
New research was presented at the 2021 Alzheimer’s Association International Conference (AAIC) showing that cleaner air could reduce an individual’s risk of developing dementia. This
New Blood Test to Significantly Improve Detection of Recurring Cancer
A new blood test known as Signatera has shown incredible ability to detect cancer relapses long before traditional scans, making it a game changer for patients.
New Parp Inhibitor Lynparza May Be Important Tool for Treating Early-Stage Breast Cancer
The President of the American Society for Clinical Oncology shared that new research has found that the Lynparza parp inhibitor could have a significant impact
How New Research Into Ancestry Can Help With Alzheimer’s Disease Awareness and Management
New research finds a connection between ancestry and Alzheimer’s disease, which can help improve early detection and management.
Ezer Mizion: My Passion Project
Read about Alex Dembitzer’s connection to Ezer Mizion, an organization in Israel that has impacted the lives of thousands in need.
New Remarkable Results in PARP Inhibitors Research Tackling Advanced and Returning Ovarian Cancer
Findings from a PARP inhibitor study presented at the Society of Gynecologic Oncology’s virtual medical conference have shown promising results.
Understanding BRCA1 and BRCA2 Mutation Genes: Risk, Prevention, and Moving Forward
What are BRCA1 and BRCA2 mutated genes? Who is at risk? What does prevention/counseling look like for those with the mutation?